Podcasts about antibiotic resistance

The lack of precision in identifying the infections that cause interstitial cystitis (IC), chronic bladder infections, prostate infections, chronic sinus infections, and more has led to mistreatment, ongoing suffering, and ineffective care. But that's changing thanks to MicroGenDX, a leader in molecular diagnostics.   Key Takeaways To Tune In For: (01:09) Introducing MicroGen DX (06:11) The Importance of Evidence-Based Medicine (10:30) Real-World Impact of MicroGen Testing (18:05) Antibiotic Resistance and Its Consequences (24:06) Genotypic vs. Phenotypic Sensitivity (30:30) Navigating the Healthcare System     Resources talked about in this episode: Website: microgendx.com View and sign the petition to get the testing covered by insurance.

How does one transform a personal crisis into a groundbreaking business that has the potential to change lives? This question lies at the heart of this episode, as we explore the journey of entrepreneurship through the lens of resilience, innovation, and a relentless drive to make a difference.Our guest, Martha Carlin, transitioned from a career in accounting to founding BiotiQuest after her husband's early Parkinson's diagnosis. Motivated to find solutions outside traditional medicine, Martha uncovered the power of the microbiome and developed specialized probiotics, leveraging years of research and personal investment to help improve lives—including her husband's.This episode provides an inside look at Martha's incredible story, the unique science behind her products, and the significant challenges small health businesses face in the era of digital marketplace giants. It's a must-listen for anyone interested in health, entrepreneurship, or what it truly takes to pursue a mission-driven business in today's digital world. To get the latest from Martha Carlin, you can follow her below!https://www.linkedin.com/in/marthacarlin/https://biotiquest.com/ Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

A new international study involving researchers from Durham University has revealed that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils. The findings, published in the journal Nature Ecology & Evolution, highlight a new and deeply concerning less seen consequence of global warming to public health. Rising antibiotic resistance in soils The study shows that rising global temperatures are significantly increasing the abundance of antibiotic resistance genes (ARGs) and virulence factors in soil microbial communities. These genes can make bacteria less susceptible to the effects of antibiotics, increasing the probability of acquiring antibiotic resistant infections, including from dangerous pathogens. The research, which integrates field data, metagenomic analysis, and laboratory experiments, provides compelling evidence that warmer conditions will favour the survival and evolution of pathogenic and other bacteria that are resistant to therapeutic treatment - bacteria that often originate in the natural environment. Professor David W. Graham of Durham University, co-author of this study, a water engineer and expert in antibiotic resistance, says "the study exemplifies how closely connected human health is with environmental change." This research provides compelling evidence that climate change is more than an environmental crisis, it also is impacting global antibiotic resistance due to warming. This research forms part of a growing body of evidence that environmental factors, including global warming, are playing a crucial role in the spread of antimicrobial resistance. It underscores the importance of a 'One Health' approach that recognises the interconnected nature of human, animal, and environmental health. Professor Graham said: "Most people do not realise that most of the pathogens that cause infectious disease humans actually originate from the environment. "Therefore, increasing resistance in soils will almost certainly translate into increased levels of untreatable infections in human and veterinary practice. This is why One Health solutions are important". The study found that the impact of warming will be more pronounced in colder regions. In the past, colder temperatures normally kill off bacteria, especially human pathogens, but as temperatures increases, such strains will survive longer, which this study shows. As temperatures rise, bacteria also appear to changing on an evolutionary level, with an increased probability of genetic changes and the appearance of 'new' pathogens to which no antibiotic options exist. Professor Graham said: "The relationship between climate and antibiotic resistance was predicted in the 2023 United Nations report: Bracing for Superbugs: Strengthening environmental action in the One Health response to antimicrobial resistance and the new work here provides concrete evidence for that prediction." The research team found that even modest increases in temperature can trigger significant rises in the abundance of ARGs, particularly in bacterial groups such as Proteobacteria and Bacteroidetes, which are known carriers of resistance and virulence genes. Laboratory experiments with Escherichia coli confirmed that elevated temperatures lead to increased expression of antibiotic resistance genes, including those involved in efflux pumps and stress response proteins, which are key mechanisms in bacterial defence. Moreover, machine learning models used in the study project that, under high-emission climate scenarios, global levels of soil ARGs could rise by up to 23 percent by the end of this century. The researchers warn that climate-driven changes to microbial communities could undermine efforts to control antibiotic resistance and may lead to greater risks of infection from previous antibiotic-susceptable bacteria from soils and, more importantly, an increased probability new pathogen 'jumping' from environmental sources ...

Broadcast from KSQD, Santa Cruz on 6-05-2025: Dr. Dawn answers an email about Dupuytren's contracture treatment, explaining her clinic experience using acupuncture anesthesia combined with Traumeel injections directly into palm nodules. She describes how this anti-inflammatory homeopathic compound, when injected into tendon sheaths, can break the cycle of fibrosis formation. Dr. Dawn explores fascinating quantum physics concepts involving collagen microstructure, water molecules, and hydrogen ion movement that may explain how acupuncture and homeopathy work through crystalline formations in collagen tubules. She discusses vitamin A's critical role in measles complications, explaining how deficiency dramatically increases risks of encephalitis and cardiac damage. Dr. Dawn covers two forms of dietary vitamin A - beta carotene from plants requiring enzymatic conversion, and vitamin A from animal products. She warns about vitamin A toxicity risks, particularly birth defects in pregnancy, while noting that typical American diets are adequate unlike vitamin D. Dr. Dawn examines vitamin D deficiency affecting 68% of children in a South Florida study, linking inadequate levels to bone health, immune function, and gut barrier integrity. She explains how vitamin D receptors throughout the body regulate cell differentiation, insulin secretion, and tight junction formation that prevents leaky gut syndrome. There are higher deficiency rates in darker-skinned populations and the historical context of rickets during industrialization when urban environments blocked sunlight exposure. She highlights revolutionary medical technology, the world's smallest pacemaker for newborns, half the size of a rice grain. This injectable device dissolves naturally after hearts self-repair, controlled by light-emitting patches communicating through the baby's skin. This breakthrough eliminates risky surgical removal procedures that caused complications, such as Neil Armstrong's death from pacemaker wire infections. Dr. Dawn discusses research showing shingles vaccination reduces dementia risk by 20%, particularly in women. She explains the natural experiment in Wales where universal healthcare created clear vaccination cutoff dates, allowing researchers to compare dementia rates. Dr. Dawn hypothesizes that cross-immunity against herpes viruses may protect brain tissue, noting even stronger protection with newer Shingrix vaccines compared to older Zostavax. She covers alarming increases in invasive Group A Streptococcus infections, with cases more than doubling from 2013 to 2022. Dr. Dawn explains how flesh-eating bacteria secretes enzymes that dissolve epithelial barriers in throats and lungs, allowing systemic spread that destroys tissue. She links rising cases to increasing diabetes and obesity rates that compromise immune function, noting devastating mortality rates approaching 10,000 deaths nationwide. Dr. Dawn celebrates a breakthrough antibiotic discovery of Lariocidin which works against highly drug-resistant bacteria through novel protein synthesis inhibition. She explains how antibiotic resistance spreads between bacterial species just like social media memes, emphasizing the urgent need for new treatments as 4 million people die annually from resistant infections. Dr. Dawn advocates for public funding since pharmaceutical companies avoid antibiotic development due to poor profit margins. She answers an email about Epstein-Barr virus detection, explaining its role in mononucleosis, Burkitt's lymphoma, and chronic fatigue syndrome. Dr. Dawn describes how EBV can remain dormant and reactivate during stress or immunocompromise, potentially triggering autoimmunity. She discusses similarities between EBV reactivation, Lyme disease, and long COVID, suggesting they may represent variations of the same inflammatory syndrome with different triggers. She explores the nocebo effect - how negative expectations worsen outcomes - and its amplification through social media. Dr. Dawn cites studies showing people warned about erectile dysfunction or altitude headaches experience these symptoms more frequently. She discusses recent phenomena like TikTok-induced tics and vaccine side effect amplification, warning that online health information creates dangerous nocebo loops that spread faster than traditional word-of-mouth.

Broadcast from KSQD, Santa Cruz on 6-05-2025: Dr. Dawn answers an email about Dupuytren's contracture treatment, explaining her clinic experience using acupuncture anesthesia combined with Traumeel injections directly into palm nodules. She describes how this anti-inflammatory homeopathic compound, when injected into tendon sheaths, can break the cycle of fibrosis formation. Dr. Dawn explores fascinating quantum physics concepts involving collagen microstructure, water molecules, and hydrogen ion movement that may explain how acupuncture and homeopathy work through crystalline formations in collagen tubules. She discusses vitamin A's critical role in measles complications, explaining how deficiency dramatically increases risks of encephalitis and cardiac damage. Dr. Dawn covers two forms of dietary vitamin A - beta carotene from plants requiring enzymatic conversion, and vitamin A from animal products. She warns about vitamin A toxicity risks, particularly birth defects in pregnancy, while noting that typical American diets are adequate unlike vitamin D. Dr. Dawn examines vitamin D deficiency affecting 68% of children in a South Florida study, linking inadequate levels to bone health, immune function, and gut barrier integrity. She explains how vitamin D receptors throughout the body regulate cell differentiation, insulin secretion, and tight junction formation that prevents leaky gut syndrome. There are higher deficiency rates in darker-skinned populations and the historical context of rickets during industrialization when urban environments blocked sunlight exposure. She highlights revolutionary medical technology, the world's smallest pacemaker for newborns, half the size of a rice grain. This injectable device dissolves naturally after hearts self-repair, controlled by light-emitting patches communicating through the baby's skin. This breakthrough eliminates risky surgical removal procedures that caused complications, such as Neil Armstrong's death from pacemaker wire infections. Dr. Dawn discusses research showing shingles vaccination reduces dementia risk by 20%, particularly in women. She explains the natural experiment in Wales where universal healthcare created clear vaccination cutoff dates, allowing researchers to compare dementia rates. Dr. Dawn hypothesizes that cross-immunity against herpes viruses may protect brain tissue, noting even stronger protection with newer Shingrix vaccines compared to older Zostavax. She covers alarming increases in invasive Group A Streptococcus infections, with cases more than doubling from 2013 to 2022. Dr. Dawn explains how flesh-eating bacteria secretes enzymes that dissolve epithelial barriers in throats and lungs, allowing systemic spread that destroys tissue. She links rising cases to increasing diabetes and obesity rates that compromise immune function, noting devastating mortality rates approaching 10,000 deaths nationwide. Dr. Dawn celebrates a breakthrough antibiotic discovery of Lariocidin which works against highly drug-resistant bacteria through novel protein synthesis inhibition. She explains how antibiotic resistance spreads between bacterial species just like social media memes, emphasizing the urgent need for new treatments as 4 million people die annually from resistant infections. Dr. Dawn advocates for public funding since pharmaceutical companies avoid antibiotic development due to poor profit margins. She answers an email about Epstein-Barr virus detection, explaining its role in mononucleosis, Burkitt's lymphoma, and chronic fatigue syndrome. Dr. Dawn describes how EBV can remain dormant and reactivate during stress or immunocompromise, potentially triggering autoimmunity. She discusses similarities between EBV reactivation, Lyme disease, and long COVID, suggesting they may represent variations of the same inflammatory syndrome with different triggers. She explores the nocebo effect - how negative expectations worsen outcomes - and its amplification through social media. Dr. Dawn cites studies showing people warned about erectile dysfunction or altitude headaches experience these symptoms more frequently. She discusses recent phenomena like TikTok-induced tics and vaccine side effect amplification, warning that online health information creates dangerous nocebo loops that spread faster than traditional word-of-mouth.

Matters Microbial #93: Preventing Antibiotic Resistance May 29, 2025 Today's episode was an in-person podcast at the University of Texas Austin!  Dr. Despoina Mavridou, Assistant Professor of Molecular Biosciences, joins the #QualityQuorum to discuss how her research group improves antibiotic effectiveness by impeding protein folding, and why this matters in the fight against antimicrobial resistance. Host: Mark O. Martin Guest: Despoina Mavridou Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode Here is a link to a wonderful video of the #LuxArt by UT-Austin students during my visit. Please give it watch and enjoy the creativity and positive #MicrobialPR. An effective TED talk by science journalist Maryn McKenna describing the threat of AMR in an accessible fashion. A CDC report on the growing threat of AMR. A review article about antibiotics. An overview of how bacteria become resistant to antibiotics.  A very recent review of the cell wall of bacteria—often the target of antibiotics. A video overview of beta-lactam antibiotics and resistance mechanisms. An overview of how protein folding is related to activity of proteins…including AMR gene products. A wonderful article by Dr. Mavridou and coworkers, describing how altering protein folding in bacteria can make them more vulnerable to antibiotics. A less technical version of the above article; well worth your reading. Dr. Mavridou's faculty website. Dr. Mavridou's research group website, which is most interesting. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

It can come, not only from the indulgent use of drugs, but also from the exchange of genes within our own guts.

It can come, not only from the indulgent use of drugs, but also from the exchange of genes within our own guts.

Matters Microbial #89: Can AI Point Us to New Antibiotics May 1, 2025 Today, Dr. Amir Mitchell, Associate Professor of Systems Biology at the University of Massachusetts Medical School, joins the #QualityQuorum to discuss using artificial intelligence to develop new and effective antibiotics in our endless battle against drug-resistant microbes. Host: Mark O. Martin Guest: Amir MItchell Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An article exploring the impact of the microbiome on drug effectiveness. A blog post discussing the relationship between the gut microbiome and creosote metabolism in wood rats. An essay about the threat of antibiotic resistance. A more scholarly article on this topic. A CDC report of the rise of antibiotic resistance. A very moving TED talk on this topic. An overview of antibiotic resistance mechanisms. A video from Dr. Michael Baym's laboratory demonstrating how rapidly antibiotic resistance can occur. An essay discussing the use of artificial intelligence in the search for new antibiotics.  An article from Dr. Mitchell's research group discussing his approach to identity new antimicrobial compounds. Dr. Mitchell's faculty website. Dr. Mitchell's very interesting research team website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Phage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge. In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data. This conversation explores how personalized phage therapy works, its scalability, and the data challenges shaping its future. ​​What You'll Learn in This Episode: Why phage therapy is a promising solution to antibiotic-resistant infectionsHow Phage Directory connects researchers and clinicians to accelerate treatmentWhat operational hurdles exist in scaling personalized phage productionHow data science is being applied to predict effective phage-bacteria matchesWhy building infrastructure and awareness is essential to adoption in clinical care Connect with Our Guest: Sponsor: CorrDyn, a data consultancyFind out more about Phage DirectoryConnect with Jessica on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode! Resources Mentioned:  Why Language Itself Might Be Holding Back AI – by Ross Katz: https://www.linkedin.com/pulse/why-language-itself-might-holding-back-ai-ross-katz-rcl9e/?trackingId=Y6%2FH45W%2BxImfl%2By2geB6%2Bg%3D%3DBacteriophage Therapy for Multidrug-Resistant Infections – PubMed: https://pubmed.ncbi.nlm.nih.gov/40026251/Cystic Fibrosis Australia and Phage Australia Survey – medRxiv: https://www.medrxiv.org/content/10.1101/2024.05.14.24307275v1Phage Directory: https://phage.directory/

Do you keep relapsing after treating candida, SIBO or other conditions? The culprit behind these never-ending cycles may be biofilms. In this episode, I'll explain how biofilms form, help you identify signs that you have them, and recommend the best antibiofilm agents. Tune in!   Learn more about biofilms and improve your gut now! Reach out to our virtual clinic: https://drruscio.com/virtual-clinic/  

Microplastics are a real problem.  They are pretty much everywhere.  They are in our food, in the oceans, on mountains, up in the clouds, and most alarmingly, in our bodies.  All of that is already bad news, but researchers at Boston University have found that microplastics may also be contributing to antibiotic resistance in dangerous […]

Doctors here say New Zealand's high use of antibiotic medication, among the top five in the world per capita, has put us at risk. The World Health Organisation considers antimicrobial resistance as one of the top global public health threats in the 21st century. But as Victor Waters explains, a kiwi tech company is doing it's bit to prepare medical defences

This episode discusses the growing threat of sepsis, a life-threatening condition caused by the body's overwhelming response to an infection. It explores the connection between the rise in sepsis cases and the increasing problem of antibiotic resistance, highlighting the importance of effective diagnostic tools and antibiotic stewardship programs in combating this public health challenge.   About Our Speaker: Dr. Mike Broyles With more than 30 years of experience as a hospital pharmacy and laboratory director, Dr. Broyles is a leading expert on sepsis and the clinical use of drugs with a focus on antimicrobial stewardship. Prior to joining Thermo Fisher Scientific, Dr. Broyles was a consultant for over 25 years working with a large independent hospital network as pharmacy advisor chairman focused on developing and implementing hospital-wide clinical initiatives. Dr. Broyles has worked passionately throughout his career to define effective protocols and decision support processes in patient management and the use of diagnostic technology to help clinicians improve outcomes through better clinical care.

How many measles cases in 2025? Should you go to the hospital for measles? When did COVID start? How long can long COVID last? Why are microplastics bad? Covering the latest measles outbreak news, recent flu vaccine meeting updates, plus new studies on long COVID and the health effects of microplastics on the body with AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

States rush to ban food dyes ahead of federal action; NIH cuts funds for studies of vaccine hesitancy; RFK Jr. ridiculed for urging vitamin A for measles; Brain tumors in firefighters show signature of chemical exposure; Unpacking the causes of numbness, tingling and pain in lower extremities; Class-action lawsuit targets Depo-Provera as contributor to meningioma brain tumors; Uncovering the mystery of Trump's 20+ pound weight loss; Microplastics implicated in spiraling antibiotic resistance.

John Maytham speaks with Nazir Ismail, Head of Clinical Microbiology and Infectious Diseases at Wits University, about an extraordinary new discovery in the immune system that could revolutionize the fight against antibiotic-resistant infections. Scientists have found that the proteasome, previously known for recycling proteins, has an unexpected ability to produce bacteria-killing chemicals.See omnystudio.com/listener for privacy information.

Dr. Don and Professor Ben talk about the risks from kissing a raven. Dr. Don - risky ☣️ Professor Ben - risky ☣️ Ragnar raven in a lovely chatty and affectionate mood. | Raven Talking | TikTok Julie Andrews – My Favorite Things Lyrics | Genius Lyrics Elton John - Rocket Man (Official Music Video) - YouTube Salmonella ravens - Google Scholar Salmonella in Sheep in Iceland - PMC Prevalence, Characterization and Antibiotic Resistance of Salmonella Isolates in Large Corvid Species of Europe and North America Between 2010 and 2013 - Janecko - 2015 - Zoonoses and Public Health - Wiley Online Library Bacterial Diversity in Feces of Wild Bald Eagles, Turkey Vultures and Common Ravens from the Pacific Northwest Coast, U.S.A | bioRxiv Blue Oyster Cult - (Don't Fear) The Reaper (Lyrics) - YouTube

Howie and Harlan are joined by infectious disease specialist Michael Dunne to discuss the growing problem of antimicrobial resistance and what's needed to incentivize the development of new antibiotics. Harlan reflects on the controversy sparked by the release of his study on post-vaccination syndrome; Howie provides an update on the measles outbreak in Texas.  Links: Post-Vaccine Syndrome Harlan Krumholz: “Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination” “A small study on Covid vaccine safety sparks an online tempest” “Scientists Describe Rare Syndrome Following Covid Vaccinations” Antimicrobial Resistance and New Antibiotics "New bill would create a subscription payment model to jumpstart antibiotic development" Antimicrobials Working Group H.R.4127—DISARM Act of 2021 S.1355—PASTEUR Act of 2023 CDC: Antimicrobial Resistance Facts and Stats Michael Dunne: “Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales” Michael Dunne: “A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020" CDC: Core Elements of Antibiotic Stewardship "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt" "Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate" Michael Dunne: “Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody” The Measles Outbreak “An unvaccinated child has died in the Texas measles outbreak” CDC: Measles, Mumps, Rubella (MMR) Vaccine Safety WHO: Measles "Consequences of Undervaccination—Measles Outbreak, New York City, 2018-2019" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Astronomy Daily - The Podcast: S04E44In this episode of Astronomy Daily, host Anna dives into a treasure trove of exciting developments in space exploration and astronomy. From NASA's New Horizons spacecraft nearing a historic milestone to groundbreaking advancements in gravitational wave detection, this episode is packed with insights that will spark your curiosity about the cosmos.Highlights:- New Horizons Approaches Termination Shock: Discover how NASA's New Horizons spacecraft is preparing to cross the termination shock, a crucial boundary that marks the transition from our solar system to interstellar space. This crossing, expected as early as 2027, could provide invaluable data about solar wind interactions and the outer heliosphere.- Breakthrough in Gravitational Wave Detection: Learn about a revolutionary advancement in adaptive optics that enhances the capabilities of gravitational wave observatories like LIGO. This technology could allow scientists to observe the universe's most dramatic events with unprecedented sensitivity, shedding light on black holes and the early universe.- Genomic Enumeration of Antibiotic Resistance in Space: Explore NASA's groundbreaking study aboard the International Space Station aimed at detecting antibiotic-resistant bacteria. This research not only safeguards astronaut health but also has significant implications for combating antibiotic resistance on Earth.- SpaceX Falcon 9 Rocket Debris Incident: Hear about the dramatic re-entry of debris from a SpaceX Falcon 9 rocket over Poland, creating a stunning light show. Fortunately, no injuries or damage were reported, but the incident highlights the complexities of space hardware re-entering Earth's atmosphere.- Firefly Aerospace's Blue Ghost Lunar Lander Update: Follow the progress of Blue Ghost as it successfully enters lunar orbit and prepares for a historic landing attempt. This mission represents a significant milestone in commercial space exploration and supports NASA's Artemis program goals.- New Tool in the Search for Extraterrestrial Life: Uncover how sulfur dioxide levels in planetary atmospheres could help identify potentially habitable worlds around red dwarf stars. This new method allows astronomers to narrow down their search for alien life by eliminating unlikely candidates.For more cosmic updates, visit our website at astronomydaily.io. Join our community on social media by searching for #AstroDailyPod on Facebook, X, YouTubeMusic, and TikTok. Don't forget to subscribe to the podcast on Apple Podcasts, Spotify, iHeartRadio, or wherever you get your podcasts.Thank you for tuning in. This is Anna signing off. Until next time, keep looking up and stay curious about the wonders of our universe.00:00 - Welcome back to Astronomy Daily01:05 - New Horizons and termination shock07:30 - Gravitational wave detection breakthrough12:15 - Antibiotic resistance study in space18:00 - Falcon 9 debris incident22:30 - Blue Ghost lunar lander update27:00 - Sulfur dioxide and extraterrestrial life32:00 - Conclusion and upcoming content✍️ Episode ReferencesNASA's New Horizons Mission[NASA TV Horizons](https://www.nasa.gov/newhorizons)Gravitational Wave Detection Technology[LIGO](https://www.ligo.caltech.edu)NASA's GEARS Experiment[NASA ISS](https://www.nasa.gov/iss)SpaceX Falcon 9 Information[SpaceX](https://www.spacex.com)Firefly Aerospace's Blue Ghost Mission[Firefly Aerospace](https://www.fireflyspace.com)Search for Extraterrestrial Life[Astrobiology](https://www.nasa.gov/astrobiology)Astronomy Daily[Astronomy Daily](http://www.astronomydaily.io)Become a supporter of this podcast: https://www.spreaker.com/podcast/astronomy-daily-space-news-discoveries--5648921/support.

In this episode of Tiny Show and Tell Us, we consider if bacteriophages could become our biggest allies in the fight against antibiotic resistance. Then we cover the historical role of "night soil men" and how some sewage treatment systems today are setting the standard for sustainable management of human excrement while also making sure we don't get sick. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.

Broadcast from KSQD, Santa Cruz on 2-06-2025: A live guest in the studio introduces Mom's Meals (momsmeals.com,) a program providing free meal delivery services for qualifying Medicare Advantage and Medi-Cal recipients with various dietary needs. During a lengthy live call, Dr. Dawn provides comprehensive guidance for a patient experiencing recurring COVID infections, discussing treatment options, long-haul symptoms, and recovery strategies. She announces FDA approval of Suzetrigine (Journavx), a novel non-opiate pain medication that works by blocking pain signals in the spinal cord, potentially marking a significant advancement in pain management. Responding to an email, Dr. Dawn provides detailed advice for treating a chronically splitting fingernail, recommending silk wrap treatment as a long-term solution. The show examines research showing omega-3 fatty acids, vitamin D, and exercise can slow biological aging, with participants aging 4 months slower over a 3-year study period. Dr. Dawn discusses concerning new research showing microplastics accumulating in mouse brains, kidneys and liver. She explores the emergence of valley fever (coccidiomycosis) as a climate change-related health threat, explaining how drones and genetic analysis are helping track its spread in California where 97% of cases originate The show explores promising research on oyster hemolymph proteins that may help combat antibiotic-resistant bacteria. A live caller follows up with a question about microplastic exposure from CPAP machines, with Dr. Dawn recommending inline bacterial paper-based filters to help capture microplastics and suggesting consultation with doctors about adjusting pressure settings to accommodate the filters.

Broadcast from KSQD, Santa Cruz on 2-06-2025: A live guest in the studio introduces Mom's Meals (momsmeals.com,) a program providing free meal delivery services for qualifying Medicare Advantage and Medi-Cal recipients with various dietary needs. During a lengthy live call, Dr. Dawn provides comprehensive guidance for a patient experiencing recurring COVID infections, discussing treatment options, long-haul symptoms, and recovery strategies. She announces FDA approval of Suzetrigine (Journavx), a novel non-opiate pain medication that works by blocking pain signals in the spinal cord, potentially marking a significant advancement in pain management. Responding to an email, Dr. Dawn provides detailed advice for treating a chronically splitting fingernail, recommending silk wrap treatment as a long-term solution. The show examines research showing omega-3 fatty acids, vitamin D, and exercise can slow biological aging, with participants aging 4 months slower over a 3-year study period. Dr. Dawn discusses concerning new research showing microplastics accumulating in mouse brains, kidneys and liver. She explores the emergence of valley fever (coccidiomycosis) as a climate change-related health threat, explaining how drones and genetic analysis are helping track its spread in California where 97% of cases originate The show explores promising research on oyster hemolymph proteins that may help combat antibiotic-resistant bacteria. A live caller follows up with a question about microplastic exposure from CPAP machines, with Dr. Dawn recommending inline bacterial paper-based filters to help capture microplastics and suggesting consultation with doctors about adjusting pressure settings to accommodate the filters.

Harmless bacteria that show antibiotic resistance and a tolerance to disinfection, have been isolated on the International Space Station.

Matters Microbial #71: Disinfecting the Built Environment December 25, 2024 Ever wonder what's growing on your toothbrush? Today, Dr. Erica Hartmann, Associate Professor of Civil and Environmental Engineering at Northwestern University, joins the #QualityQuorum to discuss how antimicrobial resistance can occur in the built environment we see all around us every day—and why it is vital to learn more about this association. Host: Mark O. Martin Guest: Erica Hartmann Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An essay on the Hygiene Hypothesis. An overview of the “built environment.” The trouble with triclosan. An essay on heavy metal resistance. An article from Dr. Hartmann's group about the toothbrush microbiome (“Project Pottymouth”). A link to the Human Microbiome Project. An overview of antibiotic resistance and antibiotic resistance genes. An article about silver nanoparticles on toothbrushes. A blog post about probiotic cleaning products. An interesting post from Dr. Hartmann's team about viruses in your bathroom. A video by Dr. Hartmann about her research. Dr. Hartmann's faculty website. Dr. Hartmann's research team website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

In this week’s episode of "The Top Line," we bring you a special conversation from earlier this month at our New York City gala, where we celebrated this year’s Fierce 50 honorees. On stage, five extraordinary leaders shared their insights, experiences, and bold ideas shaping the future of healthcare and beyond. These honorees represent the five categories of this year’s Fierce 50: health equity, innovation, social impact, breakthroughs and patient advocacy. Each honoree brings powerful insights and inspiring stories to the table. From reimagining maternal healthcare and addressing antibiotic resistance to translating public health science, transforming healthcare with AI, and tackling rural health challenges, this panel highlights innovation and disruption at its finest. To learn more about the topics in this episode: Fierce 50 of 2024 Fierce 50 of 2024 - Innovation Honorees Fierce 50 of 2024 - Health Equity Honorees Fierce 50 of 2024 - Social Impact Honorees Fierce 50 of 2024 - Breakthroughs Honorees Fierce 50 of 2024 - Patient Advocacy Honorees See omnystudio.com/listener for privacy information.

Matters Microbial #70: Food Safety and Antibiotic Resistance December 18, 2024 Today, Dr. Dr. Erika Ganda, Assistant Professor of Food Animal Microbiomes in the Department of Animal Science at Pennsylvania State University, joins the #QualityQuorum to discuss the varied interests of her research team studying the intersection of animal husbandry, microbiome studies, and the threat of antimicrobial resistance. Host: Mark O. Martin Guest: Erika Ganda Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video that Dr. Quinn and yours truly did for an event at Harvard University about #LuxArt. A video of a #LuxArt event I ran at ASMCUE a few years ago. An overview from the CDC about the One Health concept. The story of “Typhoid Mary.” An overview of rumen microbiology. The glass artwork of Jane Hartman. An article about Salmonella dublin and the impact on the dairy industry. An introduction to strategies of antibiotic resistance. A TED talk about the threat of antibiotic resistance. The concept of low level antibiotics to promote growth in chickens and other animals. A video demonstrating the swift rise of antibiotic resistance using  the MEGAPLATE approach. The accident in Brazil in 2015 releasing metal mining waste leading to increased antibiotic resistance. Evidence that microbial zinc resistance leads to increased antibiotic resistance. An explainer for proper antibiotic use. Dr. Ganda's faculty website. Dr. Ganda's research website Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

In this episode of Hart2Heart Dr. Mike Hart is joined by Dr. Sohail Gandhi to discuss the issue of the family physician shortage in the province. With 16,000 licensed family doctors but only 9,500 practicing comprehensive care, Dr. Gandhi sheds light on the reasons behind the shortage, including administrative burdens, compensation issues, and lack of respect from the government. Dr. Hart and Dr. Gandhi discuss potential solutions like improving working conditions and revisiting the healthcare system structure, including introducing deductibles and private healthcare to alleviate stress on the public system. They also dive into the role of other healthcare providers, the impact of policy decisions on patient care, and the pervasive issue of burnout among healthcare workers. Guest Bio and Links: Dr. Sohail Gandhi practices family medicine in Stayner, Ontario and has been the Investigating Coroner of Simcoe County since 2001. A graduate of the University of Toronto, Dr. Gandhi is currently an assistant clinical professor at Queen's University Medical School and a lecturer in medicine at the University of Toronto. He has held leadership positions at both the OMA and in the community, including Medical Staff Executive and Chief of Family Practice at Collingwood General and Marine Hospital, and Chair of the Board of the Georgian Bay Family Health Team. Listeners can learn more about Dr. Sohail Gandhi on his website and X @drmsgandhi  Show Notes: (0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart    (0:15) Dr. Hart introduces guest, Dr. Sohail Gandhi to the listeners (1:30) Today's topic: family physician shortage in Ontario  (3:00)  ”We've got 6,000 people already in Ontario who could do the job if we make, if we made the working conditions better.” (3:30) Misconceptions about the shortage (9:00) Solutions from other provinces (18:00) Role of pharmacists and nurse practitioners (21:30) Antibiotic resistance and healthcare challenges (28:00) Pharmacists in healthcare (30:30) Challenges in treating bladder infections (31:30) Coordinated care in Ontario (32:00) Primary care models and their effectiveness (36:30) Patient accountability in healthcare (39:30) Obesity and public health (45:30 Benefits of the Denmark healthcare system (49:00) Private vs. public healthcare systems (54:30) Burnout in the medical profession (58:00) Closing thoughts  --- Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap that exists in the medical community.  Connect on social with Dr. Mike Hart: Social Links: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##New FDA Approval for Cancer TreatmentThe FDA has recently approved a new drug for the treatment of advanced ovarian cancer. This drug has shown promising results in clinical trials, with patients experiencing longer survival rates and fewer side effects compared to traditional treatments. This approval is a significant advancement in the field of oncology and offers hope to patients who are battling this difficult disease.##Breakthrough in Alzheimer's ResearchResearchers have made a breakthrough in the field of Alzheimer's research, identifying a potential new target for treatment. By targeting this specific protein, scientists believe they may be able to slow or even reverse the progression of the disease. This discovery is a major step forward in the fight against Alzheimer's and could potentially change the lives of millions of people worldwide.##Positive Results in COVID-19 Vaccine TrialA leading pharmaceutical company has announced positive results in a phase 3 clinical trial for their COVID-19 vaccine. The vaccine has shown to be highly effective in preventing infection and has been well-tolerated by patients. This news brings hope to many as the world continues to battle the ongoing pandemic, and could potentially lead to widespread vaccination efforts in the near future.##FDA Issues Warning on Popular Diabetes MedicationThe FDA has issued a warning on a popular diabetes medication, citing potential safety concerns. Patients who are currently taking this medication are advised to speak with their healthcare provider about alternative treatment options. This warning serves as a reminder of the importance of monitoring drug safety and efficacy, and highlights the FDA's commitment to protecting public health.##Growing Concerns Over Antibiotic ResistanceHealth officials are increasingly concerned about the rise of antibiotic resistance, which poses a serious threat to public health. Overuse and misuse of antibiotics have led to the development of resistant strains of bacteria, making infections more difficult to treat. It is crucial that healthcare providers and patients alike take steps to combat this growing issue, such as practicing proper antibiotic stewardship and infection control measures.##Innovations in Gene TherapyAdvancements in gene therapy have paved the way for new treatment options for a variety of genetic disorders. By targeting specific genes, scientists are able to correct genetic mutations that cause disease, offering hope to patients who previously had limited treatment options. These innovations have the potential to revolutionize healthcare and improve outcomes for individuals living with genetic conditions.##Rise in Telemedicine UsageThe COVID-19 pandemic has led to a significant rise in telemedicine usage, as patients seek alternative ways to receive medical care while minimizing potential exposure to the virus. Telemedicine offers a convenient and accessible option for patients to consult with healthcare providers, leading to improved access to care and increased patient satisfaction. This trend is likely to continue even after the pandemic subsides, shaping the future of healthcare delivery.##Investments in Biotech StartupsInvestors are increasingly turning their attention towards biotech startups, recognizing the potential for innovation and growth in this sector. These startups are developing cutting-edge technologies and treatments that have the potential to revolutionize healthcare. The influx of investment capital is fueling research and development efforts, bringing new therapies to market at an accelerated pace. This trend highlights the importance of supporting early-stage biotech companies in driving progress within the industry.##

Welcome to Med Tech Gurus! In today's exciting episode, we are joined by Alan D. Roth, the Chief Executive at Oxford Drug Design. Alan and his team are at the forefront of leveraging artificial intelligence to revolutionize drug discovery, addressing some of the most pressing healthcare challenges, including antibiotic resistance and cancer treatment. With deep expertise in computational chemistry, Oxford Drug Design has successfully built a platform that accelerates drug development by predicting, designing, and optimizing molecules that can be produced at scale and perform effectively in real-world clinical settings. In this conversation, Alan shares the key innovations driving their Synth AI platform, which goes beyond theory to deliver viable drug candidates. We'll explore how Oxford Drug Design's platform not only identifies potent molecules but also ensures they can be manufactured cost-effectively and with clean safety profiles. Alan also discusses the importance of fostering innovation, balancing focus with creativity, and raising capital in the life sciences space. This episode provides a fascinating deep dive into AI's impact on drug discovery and offers invaluable advice for entrepreneurs looking to navigate the complex world of healthcare technology. Get ready for an insightful and inspiring discussion about the future of AI in healthcare with Alan Roth—this is one you don't want to miss!

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

Send us a textChildren under five years old are fragile. They're more vulnerable than adults to malaria, pneumonia, diarrhea, and other infections. A growing number of these infections that sicken and kill children are resistant to the drugs developed to treat them – a phenomenon known as antimicrobial resistance, or AMR.AMR is a big killer. Nearly five million deaths are caused in part by drug-resistant infections each year. While the percentage of children killed by these infections has fallen greatly since 1990, hundreds of thousands still die. Vaccines can help.  So can infection control measures as simple as handwashing routines. Patients everywhere also need to be able to get the best antibiotics to treat their infections at the right time. These infections are often more difficult to treat in low- and middle-income countries in part because they have fewer staff to clean and to care for patients, less access to effective antibiotics, and crowded neonatal units, which can worsen the spread of germs. In a special edition of One World, One Health recorded for AMR Awareness Week, we spoke with Dr. Heather Finlayson, a Pediatric Infectious Diseases Specialist at Stellenbosch University's Tygerberg Hospital in Cape Town, South Africa.Listen as she tells us about her struggles fighting drug-resistant superbugs in the youngest of children.

Are antibiotics negatively impacting our health? Tune in for an inspiring discussion with Dr. Brian Huber on The Silent Crisis of Antibiotic Resistance for Diabetic Patients.Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio affiliate!  Dr. Brian J. Huber, D.V.M., A.B.V.P., is the founder and CEO of Advanced Performance Technology, an Indiana and Texas-based company that has created novel over-the-counter medications to treat wounds, resistant bacterial and fungal infections, and other conditions. Dr. Huber has over 30 years of experience working in the human medical and veterinary arenas.  http://www.aptdeliverysystem.comFor more show information visit: www.MariannePestana.com#healing #healingjourney #diabetic #antibioticresistance #DrBrianHuber #woundcare #healthcare #health #wellbeing #wellness #medical #medicine #APT #APTT3X

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as they discuss the urgency of tackling antimicrobial resistance and the coordinated global efforts needed to save the struggling market of antibiotics.  Extended Release is an Off Script series to revisit conversations with our sources and explore new developments, gain deeper insights, and provide updates on the impact of their work. 

एंटीबायोटिक की खोज मानव जाति के लिए एक महत्वपूर्ण क्षण था। इससे इंसानों का जीवनकाल बढ़ा और स्वास्थ्य सेवा में क्रांतिकारी बदलाव आया क्योंकि लोग अब मामूली चोटों और संक्रमणों के कारण नहीं मर रहे थे। लेकिन अब एक नया खतरा मंडरा रहा है - सुपरबग बैक्टीरिया अब तक खोजे गए एंटीबायोटिक्स के प्रति तेजी से प्रतिरोधी होते जा रहे हैं। एंटीबायोटिक प्रतिरोध को तेजी से बढ़ाने वाले कारण क्या हैं? इस छिपी हुई महामारी को रोकने के लिए क्या किया जा सकता है? माइक्रोबायोलॉजिस्ट और ‘व्हेन द ड्रग्स डोंट वर्क' के लेखक अनिर्बान महापात्रा इस विषय को सरल बनाने और एंटीबायोटिक्स के उपयोग और दुरुपयोग से जुड़े कई मिथकों को तोड़ने के लिए हमारे साथ इस पुलियाबाज़ी पर जुड़ें। आप भी गौर से सुनिए और अगर बातें काम की लगें तो अपने परिवारजनों के साथ साझा करें। The discovery of antibiotics was a pivotal moment for humankind. Lifespan increased and healthcare was revolutionized as people were no longer dying due to minor injuries and infections. But now, there is a real danger of losing the evolutionary arms race with superbug bacterias, who are increasingly becoming resistant to the antibiotics we have discovered so far. What are the causes that's fast tracking antibiotic resistance? What can be done to arrest this hidden pandemic? What should policymakers do? Anirban Mahapatra, microbiologist and author of ‘When The Drugs Don't Work', joins us to simplify this topic and bust the many myths that surround the use and misuse of antibiotics.  We discuss:* What are superbugs?* Bacterias are everywhere* Overuse of antibiotics* How does antibiotic resistance develop?* Horizontal Gene Transfer* Moore's law vs Eroom's law* Myths about antibiotics use* Antibiotics in agriculture and poultry farming* What should be the policy response?* Market failure in drug discoveryReadings:When The Drugs Don't Work: The Hidden Pandemic that Could End Modern Medicine by Anirban Mahapatrahttps://www.animahapatra.com/Related Puliyabaazi:मानसिक आरोग्य और हम. Importance of Mental Health.प्रयोगशास्त्र : रैण्डमाइस्ड कंट्रोल ट्रायल की कहानी. Understanding RCTs.If you have any questions for the guest or feedback for us, please comment here or write to us at puliyabaazi@gmail.com. If you like our work, please subscribe and share this Puliyabaazi with your friends, family and colleagues.Website: https://puliyabaazi.inGuest: @bhalomanushHosts: @saurabhchandra @pranaykotas @thescribblebeeTwitter: @puliyabaazi Instagram: https://www.instagram.com/puliyabaazi/Subscribe & listen to the podcast on iTunes, Google Podcasts, Castbox, AudioBoom, YouTube, Spotify or any other podcast app. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.puliyabaazi.in

In this episode of Keeping It Real, Jillian dives into the alarming rise of antibiotic-resistant bacteria and the profound dangers they pose to global health. From the overprescription of antibiotics in humans to their rampant use in factory farming, she explores how these practices are fueling the growth of "superbugs" that traditional medicines can no longer defeat. Jillian also discusses a few key strategies to combat this looming crisis, including responsible antibiotic use, sustainable farming practices, and the power of voting with our dollars. Join her for this hot take about how we can prevent a future where life-saving drugs no longer work.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Broadcast from KSQD, Santa Cruz on 10-03-2024: In response to several listener emails, Dr. Dawn expands on the benefits of Nori powder and Rhamnan sulfate, including their effects on cholesterol and the glycocalyx. TheThe type of Nori seaweed species with the high amounts of Rhamnam sulfate is monostroma nitidum (Japanese name Hitoegusa,) and can be obtained online at Https://okume.us. She then took a little time to recap the antiviral, anti-glycemic, and cardiovascular benefits of Rhamnan sulfate found in certain seaweeds. The doctor then emphasized the importance of hot water extraction for seaweed and mushrooms as dried powders to increase bioavailability of beneficial compounds. In response to another email, Dr. Dawn addressed green tea's interaction with iron which binds and prevents absorption and its potential impact on EGCG's antioxidant properties. This lead to a brief reassuring discussion about internet memes around the safety of tea consumption and debunking concerns about lead contamination in most commercial teas. We then heard about the potential link between a common artificial fragrance Musk Ambrette, which is implicated in causing early puberty in girls as young as 9 years old. Dr. Dawn briefly comments on the need for a new economic model to address the growing threat of antibiotic-resistant superbugs and the need for new antibiotics. A discussion on so-called anti-nutrients in foods, including lectins, oxalates, and phytates, and their actual impact on health. The importance of cooking methods in reducinganti-nutrients and increasing mineral availability in foods. The potential benefits of phytoestrogens, particularly from soy, in reducing cancer risk for young women. The risks associated with processed and convenience foods, particularly regarding microplastics. In response to a telephone question, the doctor gave some strategies for managing herpes outbreaks and its potential long-term effects on brain health. She also emphasized the importance of sleep and exercise for longevity and overall health.

Broadcast from KSQD, Santa Cruz on 10-03-2024: In response to several listener emails, Dr. Dawn expands on the benefits of Nori powder and Rhamnan sulfate, including their effects on cholesterol and the glycocalyx. TheThe type of Nori seaweed species with the high amounts of Rhamnam sulfate is monostroma nitidum (Japanese name Hitoegusa,) and can be obtained online at Https://okume.us. She then took a little time to recap the antiviral, anti-glycemic, and cardiovascular benefits of Rhamnan sulfate found in certain seaweeds. The doctor then emphasized the importance of hot water extraction for seaweed and mushrooms as dried powders to increase bioavailability of beneficial compounds. In response to another email, Dr. Dawn addressed green tea's interaction with iron which binds and prevents absorption and its potential impact on EGCG's antioxidant properties. This lead to a brief reassuring discussion about internet memes around the safety of tea consumption and debunking concerns about lead contamination in most commercial teas. We then heard about the potential link between a common artificial fragrance Musk Ambrette, which is implicated in causing early puberty in girls as young as 9 years old. Dr. Dawn briefly comments on the need for a new economic model to address the growing threat of antibiotic-resistant superbugs and the need for new antibiotics. A discussion on so-called anti-nutrients in foods, including lectins, oxalates, and phytates, and their actual impact on health. The importance of cooking methods in reducinganti-nutrients and increasing mineral availability in foods. The potential benefits of phytoestrogens, particularly from soy, in reducing cancer risk for young women. The risks associated with processed and convenience foods, particularly regarding microplastics. In response to a telephone question, the doctor gave some strategies for managing herpes outbreaks and its potential long-term effects on brain health. She also emphasized the importance of sleep and exercise for longevity and overall health.

How can phages, the viruses of bacteria, be used to reduce agrichemical and antibiotic use? Dr Heather Hendrickson explains.

Liz and Becca break down the widespread misuse and overuse of antibiotics and its long-term impact on your health. They explore how antibiotics, while life-saving in certain cases, can damage the gut microbiome, lead to antibiotic resistance, and contribute to chronic health issues. Learn how to protect your body if you need antibiotics and discover natural alternatives that can help you avoid their harmful effects. This episode is a must-listen for anyone concerned about their gut health and overall well-being.***

Professor Ian Henderson has spent his career searching for new treatments in the fight against antibiotic resistance superbugs

Rosemary Bartel had no idea her life was going to take a turn when she went to a hospital near her home in Chilton, Wisconsin in the United States for standard knee replacement surgery – her second such operation. She was ready to work hard to recover and return to her busy job at her Roman Catholic diocese. But Rosie developed an all-too-common infection known as MRSA—methicillin-resistant Staphylococcus aureus. It's one of the best-known examples of antimicrobial-resistant microbes, often called superbugs. The United Nations is devoting a high-level meeting to the problem in September 2024 in the hopes of getting nations to do more to fight antimicrobial resistance or AMR.Now, 15 years later, Rosie has had her leg and hip amputated because the infection got into her bones. She has suffered numerous other infections, been in comas, lost her job, lost her health insurance, and lost most of the life she had loved.“I will probably be paying hospital bills for the rest of my life,” Rosie tells One World, One Health. Rosie is one of the luckier victims of AMR. She's still alive. Five million people a year die from complications caused by these drug-resistant germs. Now, Rosie shares her story as widely as she can as part of the Patient Family Partners Network, a group of patient advocates working to improve healthcare in the United States, and the Leapfrog Group, a nonprofit patient safety advocacy organization. She's also written a book, “Rosie's Story,” about her experience with this devastating and unending infection. Listen as Rosie describes what happened to her and what she hopes to do to help stop it from happening to others

Dr Dean St Mart joins Coaches Skip Hill & Scott McNally TIME STAMPS BELOW BSG Coaching QA Podcast 265

Join Liz and Becca as they answer listener questions about the hidden complexities of H. pylori and gut health. Discover why conventional antibiotic treatments often fail and uncover the secrets to truly eradicating this stubborn bacteria. Learn about the critical role of biofilms, antibiotic resistance, and the importance of proper stomach acid levels. If you're struggling with persistent digestive issues like bloating, heartburn, or fatigue even after treatment, this episode is a must-listen. Tune in to get practical tips and expert insights on achieving optimal gut health and boosting your immune system. Don't miss out on this eye-opening discussion!***

Episode Highlights With Dr. Elisa SongThe state of children's health today, and why we are seeing some type of problemAlarming data about the rise of autoimmune disorders in children Why teenagers are at the highest risk and the most rapidly rising segment of the population for autoimmunityWhat to know about antibiotic use The time and place for antibiotics and what to do if kids need themWhen antibiotics can be avoided and what to try insteadAntibiotics are the single biggest disrupter of the gut microbiome Some experts think that antibiotic resistance will be a leading cause of death by 2050As much as 70% of antibiotic prescriptions may be unnecessary Ways to recover from antibiotic useSix questions to ask if your child is prescribed an antibioticTips for beating ear infections in kids without antibiotics What to do when your child runs a fever and debunking some fever mythsTips that work for cold and flu in kids including a well-studied herbal remedyResources We MentionHealthy Kids, Happy Kids: An Integrative Pediatrician's Guide to Whole Child Resilience by Elisa Song, MDGet Your Child Through Flu Season NaturallyHealthy Kids Happy KidsEar OiliMOM PodcastIf you need a mom friend right now, you've come to the right place.Listen on: Apple Podcasts Spotify

How Election Science Can Support DemocracyThis week, the election season shifted into full gear with the Super Tuesday slate of primaries. But as the ballot options become more cemented, it's not just pollsters and campaign operatives who are preparing for the elections—scientists are too.The Union of Concerned Scientists has established what it calls an election science task force, looking at everything from ballot design to disinformation to voting security. Dr. Jennifer Jones, program director for the Center for Science and Democracy at the Union of Concerned Scientists, joins Ira to describe the goals of the effort in the weeks and months ahead.The Genetic Roots Of Antibiotic ResistanceAntibiotic resistance—when pathogens no longer respond to the conventional antibiotic medications—is a serious medical problem. According to the CDC, over 2.8 million antibiotic-resistant infections occur in the U.S. each year, causing some 35,000 deaths. It's in part due to overprescription of antibiotics in medicine, and the widespread use of antibiotics in animal agriculture. But the problem isn't entirely of humans' making. The roots of antibiotic resistance go back millions of years.A recent study in the Proceedings of the National Academy of Sciences collected hundreds of soil and poop samples from around the world, to try to trace back the genetics of how resistance arose in Enterococcus, a genus of bacteria that live in the guts of pretty much every land animal. In the course of their analysis, the researchers identified 18 entirely new species in the genus Enterococcus, with over 1,000 genes that had never been seen before.Dr. Michael Gilmore, the Chief Scientific Officer at Mass Eye and Ear, joins Ira to talk about the study and what the team hopes to learn about the causes of antibiotic resistance.Transcripts for each segment will be available the week after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.